Problems associated with the use of drugs administered by intermittent positive pressure ventilation.
There has been an increase in the use of drugs administered by intermittent positive pressure ventilation over recent years. There are a number of problems association with this type of therapy including variable and inadequate absorption of drugs and the possibility of nosocomial infections. A number of precautionary measures are suggested to minimize these problems.
D000042:Absorption; D000336:Aerosols; D001419:Bacteria; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000378:metabolism*; D003428:Cross Infection / Q000209:etiology* / Q000517:prevention & control; D004340:Drug Contamination / Q000517:prevention & control; D006801:Humans; D007384:Intermittent Positive-Pressure Breathing; D011175:Positive-Pressure Respiration; D012138:Respiratory Therapy / Q000009:adverse effects*
D000336:Aerosols; D001993:Bronchodilator Agents